Resverlogix Notice of Conference Call & Webcast



    TSX Exchange Symbol: RVX

    CALGARY, Aug. 21 /CNW/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) is
pleased to announce that it will host a live teleconference on August 25, 2008
at 11:00 am MDT to provide a corporate update of the Company. Following the
presentation there will be a live question and answer session.
    The webcast can be accessed at the following link:
    http://services.choruscall.com/links/resverlogix080825.html

    
    Participants can also dial in for the conference call:
    Dial information is as follows:
    North American Toll Free Dial In:    1-800-319-4610
    International Dial In:              +1-604-638-5340
    

    The webcast will be available on the Resverlogix website for replay for a
period of 10 days after the event.

    About Resverlogix Corp.

    Resverlogix Corp. is a leading biotechnology company engaged in the
development of novel therapies for important global medical markets with
significant unmet needs. The NexVas(TM) program is the Company's primary focus
which is to develop novel small molecules that enhance ApoA-I. These vital
therapies address the grievous burden of atherosclerosis and other important
diseases such as acute coronary syndrome, diabetes, Alzheimer's and other
vascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a
program that aims to address burgeoning grievous diseases, such as cancer and
fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX).
For further information please visit www.resverlogix.com.

    This news release may contain certain forward-looking statements that
reflect the current views and/or expectations of Resverlogix Corp. with
respect to its performance, business and future events. Such statements are
subject to a number of risks, uncertainties and assumptions. Actual results
and events may vary significantly. The TSX Exchange does not accept
responsibility for the adequacy or accuracy of this news release.

    %SEDAR: 00019253E




For further information:

For further information: Theresa Kennedy, VP, Corporate Communications,
Resverlogix Corp., Phone: (604) 538-7072, Fax: (403) 256-8495, Email:
Theresa@resverlogix.com; Sarah Zapotichny, Manager, Investor Relations,
Resverlogix Corp., Phone: (403) 254-9252, Fax: (403) 256-8495, Email:
Sarah@resverlogix.com; Website: www.resverlogix.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890